Macular Edema Secondary to Inflammation Clinical Trials
2 recruiting trials for Macular Edema Secondary to Inflammation. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
2
Phase 3 Trials
1
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT06990399
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema...
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)
Sponsor: Kodiak Sciences IncEnrolling: 15020 locations
RECRUITINGPhase 3NCT06996080
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema...
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)
Sponsor: Kodiak Sciences IncEnrolling: 15020 locations